The Institute of Medicine is soliciting public comment on how best to responsibly share data from clinical trials.

IOM has issued a discussion framework that includes preliminary guiding principles, defined selected data, data sharing activities and specific questions for researchers, clinical trial sponsors, patients, advocacy organizations and the general public.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access